---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285231472.md"
description: "Evolus shares are trading higher after the company reported better-than-expected Q1 sales results."
datetime: "2026-05-05T15:02:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285231472.md)
  - [en](https://longbridge.com/en/news/285231472.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285231472.md)
---

# 

Evolus shares are trading higher after the company reported better-than-expected Q1 sales results.

### Related Stocks

- [EOLS.US](https://longbridge.com/en/quote/EOLS.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [U.S. kindergarten vaccine coverage falls, CDC says](https://longbridge.com/en/news/296136711.md)
- [Evolus posts scientific investor presentation on Jeuveau, Evolysse HA fillers, Profhilo skin-quality injectable portfolio](https://longbridge.com/en/news/295023087.md)
- [EOLS: Q2 revenue up 21%, positive EBITDA, raised outlook, and expanded global portfolio for sustained growth](https://longbridge.com/en/news/295022678.md)
- [Evolus (NASDAQ:EOLS) Insider Rui Avelar Sells 3,119 Shares](https://longbridge.com/en/news/280002542.md)
- [Evolus partners with IBSA to license, distribute Profhilo in US](https://longbridge.com/en/news/292072481.md)